Antiretroviral therapy for HIV-infected patients with schizophrenia: Coordinated multidisciplinary management (7 cases);Traitement antirétroviral chez des patients schizophrènes infectés par le VIH: Prise en charge multidisciplinaire coordonnée (7 cas)

Presse Medicale

Volumn 34, Issue 6, 2005, Pages 431-437

  Leclerc, Stéphanie ^a   Brunschwig, Olivier ^a   Berki Benhaddad, Zhora ^a   Soyris, Dominique ^a   Grataud, Christian ^b   Breton, Guillaume ^b   Leport, Catherine ^a   Vildé, Jean Louis ^a  

^a BICHAT HOSPITAL   (France)

^b Service D'aide a Domicile   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CAREGIVER; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MALE; OPPORTUNISTIC INFECTION; PATIENT CARE; PATIENT COMPLIANCE; SCHIZOPHRENIA; SUPPORT GROUP; T LYMPHOCYTE SUBPOPULATION; TREATMENT PLANNING; VIRUS LOAD;

EID: 16444380877     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)83937-5     Document Type: Article

References (32)

1. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP and the APROCO cohort study group. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002; 54: 1481-96.
2. Cournos F, Empfield M, Horwath E, McKinnon K, Meyer I, Phil M et al. HIV seroprevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry 1991; 148: 1225-30.
3. Volavka J, Convit A, O'Donnell J, Douyon R, Evangelista C, Czobor P. Assessment of risk behaviors for HIV infection among psychiatric inpatients. Hospital and Community Psychiatry 1992; 43: 482-5.
4. Cournos F, Guido J, Coomaraswamy S, Meyer-Bahlburg H, Nat R, Sugden R et al. Sexual activity and risk of HIV infection among patients with schizophrenia. Am J Psychiatry 1994; 151: 228-32.
5. Benveniste O, Longuet P, Duval X, Le Moing V, Leport C, Vildé JL. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatits in an AIDS patient successively treated with ritonavir ad indinavir. Clin Infect Dis 1998; 28: 1180-1.
6. Walkup J, Crystal S, Sambamoorthi U. Schizophrenia and major effective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health 1999; 89: 1101-3.
7. Mauri MC, Fabiano L, Bravin S, Ricci C, Invernizzi G. Schizophrenic patients before and after HIV infection: a case-control study. Encephale 1997; 23: 437-41.
8. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996; 276: 126-31.
9. Gottesman II, Groome CS. HIV/AIDS risks as consequence of schizophrenia. Schizophr Bull 1997; 23: 675-84.
10. Empfield M, Cournos F, Meyer I, Phil M, McKinnon K, Horwath E et al. HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am J Psychiatry 1993; 150: 47-52.
11. Zamperetti M, Goldwurm GF, Abbate E, Gris T, Muratori S, Vigo B. Attempted suicide and HIV infection: Epidemiological aspects in a psychiatric ward. Presented at the International Conference on AIDS, San Francisco, CA, June 1990.
12. Susser E, Valencia E, Miller M, Tsai W, Meyer-Bahlburg H, Nat R et al. Sexual behavior of homeless mentally ill men at risk for HIV. Am J Psychiatry 1995; 152: 583-7.
13. Gray R, Brewin E, Noak J, Wyke-Joseph J, Sonik B. A review of the literature on HIV infection and schizophrenia: implications for research, policy and clinical practice. J Psychiatr Ment Health Nurs 2002; 9: 405-9.
14. Kalichman SC, Kelly JA, Johnson J, Bulto M. Factors associated with risk for HIV infection among chronic mentally ill adults. Am J Psychiatry 1994; 151: 221-7.
15. Grassi L, Pavanati M, Cardelli R, Ferri S, Peron L. HIV-risk behaviour and knowledge about HIV/AIDS among patients with schizophrenia. Psychol Med 1999; 29: 171-9.
16. Kalichman SC, Sikkema K, Kelly JA, Bulto M. Use of a brief behavioral skills intervention to prevent HIV infection among chronic mentally ill adults. Psychiatr Serv 1995; 46: 275-80.
17. Circulaire DGS/DH n° 96-494 du 5 août 1996.
18. Sewell DD. Schizophrenia and VIH. Schizophr Bull 1996; 22: 465-73.
19. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 2000; 101: 199-24.
20. Grunebaum MF, Weiden PJ, Olfson M. Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study. J Clin Psychiatry 2001; 62: 394-9.
21. Buchanan A. A two year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992; 22: 787-97.
22. Ruscher SM, De Wit R, Mazmanian D. Psychiatric patients' attitude about medication and factors affecting non-compliance. Psychiatr Serv 1997; 48: 82-5.
23. Young JL, Spitz RT, Hillbrand M, Daneri G. Medication adherence failure in schizophrenia: a forensic review of rates, reason, treatments, and prospects. J Am Acad Psychiatr Law 1999; 27: 426-44.
24. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23: 637-51.
25. Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Ment Dis 1989; 177: 408-14.
26. Barofsky I, Connelly CE. Problems in providing effective care for the chronic psychiatric patient. In: Barofsky I, Budson RD, eds. The chronic psychiatric patient in the community: principles of treatment. New York, NY: SP Medical & Scientific Books; 1983: 83-129.
27. McEvoy JP, Freter S, Everett G, Geller JL, Appelbaum P, Apperson LJ et al. Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis 1989; 177: 48-51.
28. Kelly GR, Scott JE, Mamon J. Medication compliance and health education among outpatients with chronic mental disorders. Med Care 1990; 28: 1181-97.
29. Eckman TA, Liberman RP, Phipps CC, Blair KE. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol 1990; 10: 33-8.
30. Le Moing V, Chêne G, Carrieri MP, Besnier JM, Masquelier B, Salamon R et al. Clinical, biologic and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors. JAIDS 2001; 27: 372-6.
31. Walkup J, Sambamoorthi U, Crystal S. Incidence and consistency of antiretroviral use among HIV-infected Medicaid beneficiaries with schizophrenia. J Clin Psychiatry 2001; 62: 174-8.
32. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS 2003; 17: 179-86.